Kiyotani K - Search Results

1

Identification of RNF213 as a Potential Suppressor of Local Invasion in Intrahepatic Cholangiocarcinoma.

Chiablaem K, Jinawath A, Nuanpirom J, Arora JK, Nasaree S, Thanomchard T, Singhto N, Chittavanich P, Suktitipat B, Charoensawan V, Chairoungdua A, Jinn-Chyuan Sheu J, Kiyotani K, Svasti J, Nakamura Y, Jinawath N. Chiablaem K, et al. Among authors: kiyotani k. Lab Invest. 2024 Jul;104(7):102074. doi: 10.1016/j.labinv.2024.102074. Epub 2024 May 7. Lab Invest. 2024. PMID: 38723854

2

Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients.

Low SK, Kiyotani K, Mushiroda T, Daigo Y, Nakamura Y, Zembutsu H. Low SK, et al. Among authors: kiyotani k. J Hum Genet. 2009 Oct;54(10):564-71. doi: 10.1038/jhg.2009.79. Epub 2009 Aug 21. J Hum Genet. 2009. PMID: 19696793

3

Should CYP2D6 inhibitors be administered in conjunction with tamoxifen?

Zembutsu H, Sasa M, Kiyotani K, Mushiroda T, Nakamura Y. Zembutsu H, et al. Among authors: kiyotani k. Expert Rev Anticancer Ther. 2011 Feb;11(2):185-93. doi: 10.1586/era.10.228. Expert Rev Anticancer Ther. 2011. PMID: 21342038 Review.

4

Phosphatidylinositol glycan anchor biosynthesis, class X containing complex promotes cancer cell proliferation through suppression of EHD2 and ZIC1, putative tumor suppressors.

Nakakido M, Tamura K, Chung S, Ueda K, Fujii R, Kiyotani K, Nakamura Y. Nakakido M, et al. Among authors: kiyotani k. Int J Oncol. 2016 Sep;49(3):868-76. doi: 10.3892/ijo.2016.3607. Epub 2016 Jul 6. Int J Oncol. 2016. PMID: 27572108 Free PMC article.

5

Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens.

Kiyotani K, Chan HT, Nakamura Y. Kiyotani K, et al. Cancer Sci. 2018 Mar;109(3):542-549. doi: 10.1111/cas.13498. Epub 2018 Feb 14. Cancer Sci. 2018. PMID: 29288513 Free PMC article. Review.

6

Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations.

Miyauchi E, Matsuda T, Kiyotani K, Low SK, Hsu YW, Tsukita Y, Ichinose M, Sakurada A, Okada Y, Saito R, Nakamura Y. Miyauchi E, et al. Among authors: kiyotani k. Cancer Sci. 2019 Mar;110(3):867-874. doi: 10.1111/cas.13919. Epub 2019 Feb 16. Cancer Sci. 2019. PMID: 30582659 Free PMC article.

7

Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2.

Kiyotani K, Toyoshima Y, Nemoto K, Nakamura Y. Kiyotani K, et al. J Hum Genet. 2020 Jul;65(7):569-575. doi: 10.1038/s10038-020-0771-5. Epub 2020 May 6. J Hum Genet. 2020. PMID: 32372051 Free PMC article.

8

SARS-CoV-2 genomic variations associated with mortality rate of COVID-19.

Toyoshima Y, Nemoto K, Matsumoto S, Nakamura Y, Kiyotani K. Toyoshima Y, et al. Among authors: kiyotani k. J Hum Genet. 2020 Dec;65(12):1075-1082. doi: 10.1038/s10038-020-0808-9. Epub 2020 Jul 22. J Hum Genet. 2020. PMID: 32699345 Free PMC article.

9

Immunogenomics in personalized cancer treatments.

Kiyotani K, Toyoshima Y, Nakamura Y. Kiyotani K, et al. J Hum Genet. 2021 Sep;66(9):901-907. doi: 10.1038/s10038-021-00950-w. Epub 2021 Jun 30. J Hum Genet. 2021. PMID: 34193979 Review.

10

Personalized immunotherapy in cancer precision medicine.

Kiyotani K, Toyoshima Y, Nakamura Y. Kiyotani K, et al. Cancer Biol Med. 2021 Aug 9;18(4):955-65. doi: 10.20892/j.issn.2095-3941.2021.0032. Online ahead of print. Cancer Biol Med. 2021. PMID: 34369137 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters